News · 01 Aug 2026

Systematic Review with Meta-Analysis: Early-Life Omega-3 and Asthma Risk

Last updated:

A systematic review with meta-analysis of randomized controlled trials examined early-life omega-3 fatty acids for preventing childhood asthma and wheezing. Supplementation reduced risk in a dose-dependent manner, and dose-response analysis confirmed a linear relationship. The authors report substantial protection for high-dose regimens, particularly those involving EPA.

What the Research Says

The analysis followed PRISMA guidelines; three reviewers independently evaluated the studies and extracted data. Subgroup analyses revealed no heterogeneity with respect to study location, allergy risk or follow-up duration.

Source

Asia Pacific journal of clinical nutrition: Early-life high-dose omega-3 polyunsaturated fatty acid supplementation reduces risk of childhood asthma/wheezing: A meta-analysis of randomized controlled trials..0006) (2026-08-01)

Full evidence overview: Omega-3

All news

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/news/2026-09-omega-3/ · Last updated: 2026-09-22